B8DCJ5 AF NFT

Probable dual-specificity RNA methyltransferase RlmN

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeid3nrsxz4mqdkmqi7qqre7dk67hxlidpvlzmdz5vnjcldt7jbsxpa/metadata.json
IPFS of structure file: 
bafybeicmmir7zzzjwga6rpzbhurjsryour6jxkkkbsmqoytxpoqsmf7kru/AF-B8DCJ5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x71112d4fF7ebb3b617963c05f052289e073082FD
First NFT owner address (bech32): 
genesis1wygj6nlhawemv9uk8szlq53gncrnpqha56an79
Current NFT ID #378351 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
378351
Accession (UniProt):
B8DCJ5
Name::
Probable dual-specificity RNA methyltransferase RlmN
Experimental Method:
Predicted structure
Sequence source:
Listeria monocytogenes serotype 4a (strain HCC23)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B8DCJ5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B8DCJ5|RLMN_LISMH Probable dual-specificity RNA methyltransferase RlmN OS=Listeria monocytogenes serotype 4a (strain HCC23) OX=552536 GN=rlmN PE=3 SV=1 MEKSSIYGLTWTKLTEWLEAHGQKKFRATQVWDWLYRKRVKTFEEMSNVPKETIELLTANFVMNTLEEQVVQESTDGTTKYLFKLSDGNLIETVMMKQEYGLSVCVTTQVGCNIGCTFCASGLLKKSRDLTAGEIVEQIMNVQHYLDGRNLEERVSHVVVMGIGEPFDNYDNVMDFLRVINHDKGLAIGARHITVSTSGLAPRIIDFANEDFQVNLAISLHAPNNELRTSIMRINKTYSIEKLMEAIHYYVNKTNRRITFEYIMLKGVNDHKKEALELAALLGEHRHLAYVNLIPYNPVDEHIDYERSTKEDVLAFYDTLKKNGINCVIRREHGTDIDAACGQLRSKQIKRVGVRERMKQKQAAAEE